Ipsen Group News Today

Botulinum Toxin Market by Product Type (Type A, and Type B), by Application (Therapeutics, and Aesthetic), by End-Use (Hospitals, Dermatology Clinics, Spas and Cosmetic Centers), and by Region (North America, South America, Europe, Asia Pacific, Midd

/PRNewswire/ -- The report titled "Peptide Therapeutics Market by Technology (Hybrid Phase, Liquid Phase, Solid Phase), Drug Class (Adrenocorticotropic...

Dublin, March 27, 2024 (GLOBE NEWSWIRE) -- The

While Minimally Invasive Procedures Propel the Growth of the Global Botulinum Toxin Market, a Newly Released Report by Fairfield Market Research Says Asia...

The Botulinum Toxin Market is projected to grow from $7.92 billion in 2024 to $18.72 billion in 2032, at a CAGR of 11.3% in forecast period

Ipsen BioPharm has submitted plans to build a 120,000 sq ft manufacturing facility next to its existing warehouses off Ash Road North on the city’s industrial estate.

/PRNewswire/ -- The "Global Skeletal Dysplasia Market (2023-2028) by Type, Applications, and Geography, Competitive Analysis, Impact of Covid-19 and Ansoff...

/PRNewswire/ -- The "Botulinum Toxin: Global Strategic Business Report" report has been added to ResearchAndMarkets.coms offering. The global market for...

Dublin, May 04, 2023 (GLOBE NEWSWIRE) -- The "Botox Market Size, Share, Trends, By Type, By End-Use, By Application, By Gender, and By Region Forecast to...

Recent mergers and acquisitions (M&A) announcements in the $1 billion-and-up range suggests that biopharma may resume dealmaking this year.